I read, understand, and agree to the program requirements shown below and would like to receive a CONCERTA® (methylphenidate HCl) Extended-release Tablets CII Savings Program card.
Download and print the card and present it at a participating retail pharmacy along with a valid prescription. Your eligibility to use this card is dependent upon meeting the program requirements each time you present the card when filling your prescription.
Eligible patients using commercial or private insurance can save on out-of-pocket costs for CONCERTA®. Eligible patients pay an initial $4 per fill at participating retail pharmacies and receive up to $150 off their out-of-pocket prescription costs, with a maximum program benefit of $1,800 or 12 fills per calendar year, whichever comes first. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. Terms expire at the end of each calendar year and may change. Offer not valid in CA and MA. There is no income requirement. See program requirements below.
You may be eligible for the CONCERTA® Savings Program if you are age 6 to 65 and currently use private or commercial health insurance for CONCERTA®.
This program is in no way an extension of medical treatment provided by healthcare professionals to individual patients.
If you wish to participate in the CONCERTA® Savings Program, we will not collect your personal information before you receive a card. Upon use of the card, your information will be used by Janssen Pharmaceuticals, Inc., our affiliates, and our service providers to determine your eligibility for the CONCERTA® Savings Program, and to provide benefits to you related to the use of the CONCERTA® Savings Program card. We may also use the information you provide to learn more about the people who use CONCERTA® and to improve the information we provide to people who are being treated with CONCERTA®. Janssen Pharmaceuticals, Inc. will not share your information with anyone else except as required by law. Our Privacy Policy governs the use of information you provide.
Talk to your healthcare professional for a proper diagnosis and treatment of ADHD. Only a healthcare professional can decide whether medication is right for you or your child.
Abuse of methylphenidate may lead to dependence. Tell your healthcare professional if you or your child has had problems with alcohol or drugs. Keep CONCERTA® in a safe place to prevent misuse and abuse.
CONCERTA® should not be taken by patients who have:
Children under 6 years of age should not take CONCERTA®.
Tell your healthcare professional if you or your child has had:
Contact your healthcare professional immediately if you or your child:
Painful and prolonged erections (priapism) have occurred with methylphenidate. If you or your child develop priapism, seek medical help right away. Because of the potential for lasting damage, priapism should be evaluated by a doctor immediately.
Your child’s healthcare professional should check height and weight often and may interrupt CONCERTA® treatment if your child is not growing or gaining weight as expected.
Stimulants may impair the ability of a patient to operate potentially hazardous machinery or vehicles. Caution should be used accordingly until you are reasonably certain that CONCERTA® does not adversely affect your ability to engage in such activities.
The most common adverse reactions in double-blind clinical trials (>5%) reported:
CONCERTA® is a registered trademark of ALZA Corporation.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
cp-180018v1
CONCERTA® (methylphenidate HCl) Extended-release Tablets CII is a prescription medication approved for the treatment of attention deficit hyperactivity disorder (ADHD) as part of a total treatment program that may include counseling or other therapies.
Talk to your healthcare professional for a proper diagnosis and treatment of ADHD. Only a healthcare professional can decide whether medication is right for you or your child.
Abuse of methylphenidate may lead to dependence. Tell your healthcare professional if you or your child has had problems with alcohol or drugs. Keep CONCERTA® in a safe place to prevent misuse and abuse.
CONCERTA® should not be taken by patients who have:
Children under 6 years of age should not take CONCERTA®.
Tell your healthcare professional if you or your child has had:
Contact your healthcare professional immediately if you or your child:
Painful and prolonged erections (priapism) have occurred with methylphenidate. If you or your child develop priapism, seek medical help right away. Because of the potential for lasting damage, priapism should be evaluated by a doctor immediately.
Your child’s healthcare professional should check height and weight often and may interrupt CONCERTA® treatment if your child is not growing or gaining weight as expected.
Stimulants may impair the ability of a patient to operate potentially hazardous machinery or vehicles. Caution should be used accordingly until you are reasonably certain that CONCERTA® does not adversely affect your ability to engage in such activities.
The most common adverse reactions in double-blind clinical trials (>5%) reported:
CONCERTA® is a registered trademark of ALZA Corporation.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
cp-180018v1
CONCERTA® (methylphenidate HCl) Extended-release Tablets CII is a prescription medication approved for the treatment of attention deficit hyperactivity disorder (ADHD) as part of a total treatment program that may include counseling or other therapies.